BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Paper Recasts Alzheimer's As Cardiovascular Disorder

Nov. 1, 2011
By Anette Breindl
No Abstract
Read More

Unexpected Mechanisms Are Nixing Cancer Drug Resistance

Nov. 1, 2011
By Anette Breindl
No Abstract
Read More

Meningitis Bacteria, Their Trash Kill Epithelial Cells

Nov. 1, 2011
By Anette Breindl
No Abstract
Read More

To Find Therapeutic Leads, Hiberna Goes To Extremes

Nov. 1, 2011
By Anette Breindl
Most people don't think of Arctic ground squirrels and Burmese pythons as having much in common. But Leslie Leinwand does.In a nutshell, both animals go to physiological extremes in their lifestyles.
Read More

Study Identifies Kinase Linking Stress to Depression, Addiction

Oct. 31, 2011
By Anette Breindl
That stress, depression and addiction are linked is obvious to any psychiatrist; to many a junkie; and to University of Washington researcher Charles Chavkin.
Read More

Nanoparticle Vaccine Could Rival Live Vaccine Longevity

Oct. 31, 2011
By Anette Breindl
By using three separate immune stimulants and packaging them in a nanoparticle that mimics a live virus, researchers at Emory University were able to induce immune responses to flu virus, which were much stronger than those induced by the current vaccines – and that lasted long enough to rival the immune responses induced by live viruses.
Read More

Plexxikon BRIMs with Joy over PLX4032 Phase III Data

Oct. 31, 2011
By Anette Breindl
Melanoma drug PLX4032 has set the cancer world abuzz more than once over the past year and a half. And with an interim analysis of a Phase III trial released yesterday that showed both an overall survival benefit and a progression-free survival benefit for patients taking the drug as a first-line agent, it is doing it again.
Read More

Platelet-Derived Particles Play Role in Arthritic Inflammation

Oct. 31, 2011
By Anette Breindl
No Abstract
Read More

CeRNA Discoveries May Let Biotech Tap Noncoding RNA

Oct. 31, 2011
By Anette Breindl
A few weeks ago, a series of four papers published in Cell provided an early glimpse of a new world of RNA regulation that interacts with microRNAs: competing endogenous RNAs (ceRNA).
Read More

Easier Synthesis Reported For One Form of Heparin

Oct. 31, 2011
By Anette Breindl
By combining chemical and enzymatic synthesis, scientists have come up with a faster and cheaper way to make the smallest form of heparin.If commercialization works out, the findings could extend the market reach of ultralow molecular weight heparin, as this form is called. And the chemoenzymatic synthesis that the researchers described in the Oct. 28, 2011, issue of Science marks progress on the way to a larger goal: synthesizing full-length heparin.
Read More
Previous 1 2 … 253 254 255 256 257 258 259 260 261 … 400 401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 9, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing